Form 4: FibroGen Executive Sells Shares to Cover Tax Obligations

Christine Chung, SVP of China Operations at FibroGen, sold 2,792 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Christine Chung, a Senior Vice President at FibroGen, sold 2,792 shares of common stock on December 6, 2024.
• The sale was executed to cover tax obligations arising from the vesting of restricted stock units.
• The price per share was $0.3421.
• Following the transaction, Ms. Chung directly owns 301,552 shares of FibroGen stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any positive or negative sentiment.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, and is common in publicly traded companies.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a standard practice across publicly traded companies.
• The number of shares sold is relatively small compared to the total holdings of the executive, suggesting this is a routine transaction rather than a significant divestment.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

FibroGen, stock sale, insider trading, Form 4, executive compensation, tax obligations, restricted stock units